L Xu1, Z Li1, S-Y Liu1, S-Y Xu1, G-X Ni2. 1. Department of Orthopeadics and Traumatology, Nanfang Hospital, Southern Medical University, China. 2. Department of Orthopeadics and Traumatology, Nanfang Hospital, Southern Medical University, China. Electronic address: fgxni@graduate.hku.hk.
Abstract
OBJECTIVE: To provide an overview of the literature describing the role of asporin, a small leucine-rich proteoglycan (SLRP), in osteoarthritis (OA). METHOD: A literature search was performed and reviewed using the narrative approach. RESULTS: As a class I SLRP member, asporin, is distinct from other SLRPs. Accumulating evidence demonstrates the involvement of asporin in OA pathogenesis. Many human studies have been conducted to explore the association between the D-repeat polymorphisms and OA susceptibility, but these yield inconsistent results. Possible mechanisms for the involvement of asporin in OA pathology include its influence on TGF-β (transforming growth factor-β) signaling pathways and collagen mineralization. To date, no studies were found to use an asporin-deficient animal model that would help to understand disease mechanisms. Many issues must be addressed to clarify the link between asporin and OA to provide a novel therapeutic strategy for OA, perhaps through controlling and modifying the TGF-β-ECM system. CONCLUSIONS: Studies examined demonstrate the involvement of asporin in OA pathogenesis, and possible mechanisms by which asporin may be involved in this process have been proposed. However, large-scale interracial studies should be conducted to investigate the association between asporin and OA, and further investigations are needed to obtain a better understanding of the disease mechanism, develop novel therapeutic strategies, and explore new approaches for diagnosis of OA.
OBJECTIVE: To provide an overview of the literature describing the role of asporin, a small leucine-rich proteoglycan (SLRP), in osteoarthritis (OA). METHOD: A literature search was performed and reviewed using the narrative approach. RESULTS: As a class I SLRP member, asporin, is distinct from other SLRPs. Accumulating evidence demonstrates the involvement of asporin in OA pathogenesis. Many human studies have been conducted to explore the association between the D-repeat polymorphisms and OA susceptibility, but these yield inconsistent results. Possible mechanisms for the involvement of asporin in OA pathology include its influence on TGF-β (transforming growth factor-β) signaling pathways and collagen mineralization. To date, no studies were found to use an asporin-deficient animal model that would help to understand disease mechanisms. Many issues must be addressed to clarify the link between asporin and OA to provide a novel therapeutic strategy for OA, perhaps through controlling and modifying the TGF-β-ECM system. CONCLUSIONS: Studies examined demonstrate the involvement of asporin in OA pathogenesis, and possible mechanisms by which asporin may be involved in this process have been proposed. However, large-scale interracial studies should be conducted to investigate the association between asporin and OA, and further investigations are needed to obtain a better understanding of the disease mechanism, develop novel therapeutic strategies, and explore new approaches for diagnosis of OA.
Authors: K Nagasaki; M B Chavez; A Nagasaki; J M Taylor; M H Tan; M Ma; E Ralston; M E Thew; D-G Kim; M J Somerman; B L Foster Journal: J Dent Res Date: 2022-06-09 Impact factor: 8.924
Authors: Kasper Huétink; Paul van der Voort; Johan L Bloem; Rob G H H Nelissen; Ingrid Meulenbelt Journal: Clin Med Insights Arthritis Musculoskelet Disord Date: 2016-04-28
Authors: Anke Jeschke; Martin Bonitz; Maciej Simon; Stephanie Peters; Wolfgang Baum; Georg Schett; Wolfgang Ruether; Andreas Niemeier; Thorsten Schinke; Michael Amling Journal: PLoS One Date: 2015-12-02 Impact factor: 3.240
Authors: Shu Yang; Zhihua Xing; Tao Liu; Jing Zhou; Qinghua Liang; Tao Tang; Hanjin Cui; Weijun Peng; Xingui Xiong; Yang Wang Journal: Drug Des Devel Ther Date: 2018-03-06 Impact factor: 4.162